Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Plos One|March 25, 2014
Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cellsJeannine Diesch, Elaine Sanij, Omer Gilan, et al.Clinical Epigenetics|April 24, 2021
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysisSarah Bazzocco, Higinio Dopeso, Águeda Martínez-Barriocanal, et al.The Journal of Nutrition|July 4, 2003
Application of gene expression profiling to colon cell maturation, transformation and chemopreventionLeonard H Augenlicht, Anna Velcich, Lidija Klampfer, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2019
Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancerDavid S Williams, Dmitri Mouradov, Clare Browne, et al.Cancer Research|October 1, 2009
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionZiqiang Yuan, Joongho Shin, Andrew Wilson, et al.Growth Factors (Chur, Switzerland)|August 21, 2013
Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenograftsSze Ting Lee, Hong Ji, David W Greening, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2023
In colon cancer cells fascin1 regulates adherens junction remodelingAmin Esmaeilniakooshkghazi, Eric Pham, Sudeep P George, et al.Journal of Proteomics|October 1, 2008
Proteomic changes during intestinal cell maturation in vivoJinsook Chang, Mark R Chance, Courtney Nicholas, et al.Gut|November 16, 2011
β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cellsHelena J M Smartt, Alexander Greenhough, Paloma Ordóñez-Morán, et al.Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.Pageof 12